Free Trial
OTCMKTS:TRUMY

Terumo Q4 2025 Earnings Results & Report

Terumo logo
$15.05 0.00 (0.00%)
As of 11/13/2026 03:55 PM Eastern

Terumo missed analyst expectations on both earnings and revenue in its Q4 2025 results, released May 14, 2025. The company reported EPS of $0.08 versus the $0.1454 consensus estimate, while revenue of $1.79 billion fell short of the $1.79 billion estimate by $7.40 million.

Earnings Announcement Details

Quarter
Q4 2025
Report Date
Time
Before Market Opens

Terumo EPS Results

Actual EPS
$0.08
Consensus EPS
$0.1454
Beat/Miss
Missed by -$0.0654
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 8 quarters

Terumo Revenue Results

Actual Revenue
$1.79 billion
Expected Revenue
$1.79 billion
Beat/Miss
Missed by -$7.40 million
YoY Revenue Growth
N/A

Conference Call Resources

Terumo Q4 2025 Earnings FAQ

Terumo (OTCMKTS:TRUMY) reported earnings of $0.08 per share for Q4 2025, missing the consensus estimate of $0.1454. The report was announced on Wednesday, May 14, 2025.

Terumo reported revenue of $1.79 billion for Q4 2025, against a consensus estimate of $1.79 billion.

Terumo Earnings Headlines

Terumo (OTCMKTS:TRUMY) Shares Gap Down Following Weak Earnings
Executive Order 14241 Unleashes Trump’s New Dollar
A landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December. The agenda at the upcoming G20 Summit in Miami has shifted, and new research points to a major monetary announcement from President Trump. A new documentary breaks down what this shift could mean for savings, investments, and the assets tied to it.tc pixel
Terumo (OTCMKTS:TRUMY) Stock Falls 7.4% Following Weak Earnings
Terumo Corporation (TRUMY) Q2 2027 Earnings Call Transcript
Terumo ADR (TRUMY) Ratios
See More Terumo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Terumo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Terumo and other key companies, straight to your email.

About Terumo

Terumo (OTCMKTS:TRUMY) Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services.

Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies.

Headquartered in Tokyo, Terumo serves healthcare customers in Japan and markets around the world. Its products support areas including patient care, cardiovascular treatment, transfusion medicine and cell therapy.

View Terumo Profile